Abstract
The objective of this study was to compare the spread of pertussis in children and adults being secondary contacts after household exposure. The study was nested in an efficacy trial of an acellular pertussis vaccine. The spread of the disease was also monitored with respect to gender and antibiotic therapy. A total of 453 index cases, of which 133 were monitored for adult disease, fulfilled the WHO definition of pertussis. They had contacts to 173 unvaccinated children aged 6–47 months, and a total of 101 adults with pertussis were followed. Detection of the bacteria, or a significant increase of specific antibodies confirmed the diagnosis. Secondary spread of the disease was assumed, when a household member coughed for 7 days or more and had laboratory evidence for pertussis. Crude attack rates (AR) were 69% in children and 31% in adults (P < 0.05). AR in children were independent of gender but more women than men (P = 0.02) were affected in those households where the index case was a child. Erythromycin treatment of the index case reduced the AR in exposed toddlers from 80% to 57% (P = 0.06), and in exposed adults from 40% to 21% (P = 0.2). Erythromycin therapy in contacts did not alter the clinical course of the disease significantly.
Conclusions
In a household study of pertussis, 69% of children and 31% of adults (more women than men) contracted the disease. Erythromycin reduced the number of infections in household contacts, but did not alter the clinical course in those who contracted pertussis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- AR:
-
attack rates
References
Aoyama T, Murase Y, Kato T, Iwata T (1985) Efficacy of acellular pertussis vaccine in Japan. J Pediatr 107:180–183
Bass JW (1986) Erythromycin for treatment and prevention of pertussis Pediatr. Infect Dis J 5:154–157
Clark AC, Bradford WI, Berry GP (1946) An epidemiological study of an outbreak of pertussis in a public school. Am J Public Health 36:1156–1162
Fine PEM, Clarkson JA, Miller E (1988) The efficacy of pertussis vaccines under conditions of household exposure. Further analysis of the 1978-1980 PHLS/ERL study in 21 areas health authorities in England. Int J Epidemiol 17:635–642
Finger H, Wirsing von Koenig CH, Tacken A, Wassilak SGF (1991) The epidemiological situation of pertussis in the Federal Republic of Germany. Dev Biol Stand 73:343–355
Giammanco A, Chiarini A, Stroffolini T, et al (1991) Seroepi-demiology of pertussis in Italy, Rev Infect Dis 13:1216–1220
Granstroem G, Sterner G, Nord CE, Granstroem M (1987) Use of erythromycin to prevent pertussis in newborns of mothers with pertussis. J Infect Dis 155:1210–1214
Heininger U, Cherry JD, Eckardt T, Lorenz C, Christenson P, Stehr K (1993) Clinical and laboratory diagnosis of pertussis in the regions of a large vaccine efficacy trial in Germany. Pediatr Infect Dis J 12:504–509
Isacson J, Trollfors, B, Taranger J, Lagergard T (1985) Acquisition of IgG serum antibodies against two Bordetella antigens (filamentous hemagglutinin and pertactin) in children with no symptoms of pertussis. Pediatr Infect Dis J 14:517–521
Isomura S (1991) Clinical studies on efficacy and safety of an acellular pertussis vaccine in Aichi prefecture, Japan. Dev Biol Stand 73:37–42
Kato T, Goshima T, Nakajima N, Kaku H, Arimoto Y, Hayashi F (1989) Protection against pertussis by accellular pertussis vaccines (Takeda, Japan): household contact studies in Kawasaki City, Japan. Acta Paediatr Jpn 31:698–701
Kendrick PL (1940) Secondary familial attack rates from pertussis in vaccinated and unvaccinated children. Am J Hygiene 32:98–101
Mortimer EAJr (1990) Pertussis and its prevention: a family affair. J Infect Dis 161:473–479
Mortimer EA, Kimura M, Cherry JD et al (1990) Protective efficacy of the Takeda acellular pertussis vaccine combined with diphtheria and tetanus toxoids following household exposure in Japan. Am J Dis Child 144:899–904
Patriarca PA, Biellik MJ, Sanden G et al (1988) Sensitivity and specificity of clinical case definitions for pertussis. Am J Publ Health 78:833–836
Schmitt HJ, Wirsing von König CH, Neiss A, et al. (1996) Efficacy of acellular pertussis vaccine in each child after household exposure. JAMA 275:37–41
Simondon F (1996) Senegal pertussis trial, Abstracts NIH Pertussis Conference, 3–5 June 1996, Washington, D.C.
Stallybrass CO (1931) The principles of epidemiology and the process of infection. Routledge, London
Steketee RW, Wassilak SGF, Adkins GN, et al (1988) Evidence for a high attack rate and efficacy of erythromycin prophylaxis in a pertussis outbreak in a facility for the developmentally disabled. J Infect Dis 157:434–440
StorsaeterJ, Gustaffson L (1996) Swedish household study, estimates of vaccine efficacy and preliminary indications of serological correlates between antibody levels in pre-exposure sera and protection against pertussis among household exposed study children. Abstracts NIH Pertussis Conference, 3–5 June 1996, Washington, D.C.
Strebel PM, Cochi SL, Farizo KM, Payne BJ, Hanauer SD, Baughman AL (1992) Pertussis in Moussouri: evaluation of nasopharyngeal culture, direct fluorescent antibody testing, and clinical case definitions in the diagnosis of pertussis. Clin Infect Dis 16:176–185
Taranger J, Trollfors B, Lagergard T, et al (1997) Unchanged efficacy of a pertussis toxoid vaccine throughout the two years after the third vaccination of infants Pediatr Infect Dis J 16:180–184
WHO Meeting on Case Definitions of Pertussis, 10–11 January 1991 MIN/EPI.PERT91.1 p 4–5
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
König, C.H.W.v., Postels-Multani, S., Bogaerts, H. et al. Factors influencing the spread of pertussis in households. Eur J Pediatr 157, 391–394 (1998). https://doi.org/10.1007/s004310050836
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s004310050836